On 31 May 2017 the FORUM Institut für Management hosts an SPC related event in Amsterdam, entitled: Quo vadis, SPC?

Dr. Christopher Brückner discusses the SPC referrals to the CJEU. He will put the decisions in context and will show the consequences for national court practice and for the application practice.

Topics
Laying the ground: referrals since Medeva
Eli Lilly, Actavis and Georgetown II: referrals in context, background and interpretation
Impact on application practice and national court practice
Forsgren, Seattle Genetics, F. Hoffmann – La Roche
Pending referrals: Merck Sharp & Dohme (2016)
Open questions for further potential referrals

More information on this event can be found here.